ClinicalTrials.Veeva

Menu

Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar Tendinopathy (ppns)

H

Hospital Clinic of Barcelona

Status

Enrolling

Conditions

Patellar Tendinopathy / Jumpers Knee

Treatments

Device: Electrical stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT07237867
2025-04-05

Details and patient eligibility

About

This study investigates the immediate effects of different peripheral electrical nerve stimulation protocols applied to the femoral nerve on quadriceps strength in athletes with patellar tendinopathy. Patellar tendinopathy is a common overuse injury that often reduces quadriceps activation and limits sports performance. Peripheral percutaneous nerve stimulation (PPNS) and transcutaneous electrical nerve stimulation (TENS) are frequently used in rehabilitation, but their frequency-dependent effects on muscle strength are not well established.

In this randomized crossover trial, each participant receives three stimulation protocols in separate sessions: high-frequency PPNS (100 Hz), low-frequency PPNS (2 Hz), and conventional TENS. All stimulation is delivered at the maximal tolerated motor threshold and, for PPNS conditions, under ultrasound guidance. Quadriceps maximal isometric strength is evaluated using an isometric force sensor before and after each intervention.

The primary objective is to compare the acute changes in maximal voluntary contraction (MVC) following each stimulation protocol. The study aims to clarify whether different stimulation frequencies can enhance, reduce, or have no effect on quadriceps strength in this athletic population.

By identifying frequency-specific neuromodulatory responses, this study may help clinicians and sports practitioners select the most appropriate stimulation parameters to optimize rehabilitation and performance in individuals with patellar tendinopathy.

Enrollment

19 estimated patients

Sex

Male

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 to 40 years.
  • Recreational or competitive athletes with clinically diagnosed patellar tendinopathy for at least 3 months.
  • Ultrasound-confirmed patellar tendinopathy, including hypoechoic areas, tendon thickening, or neovascularization consistent with clinical diagnosis.

Presence of pain during tendon-loading activities (e.g., jumping, running, squatting).

  • Ability to perform maximal voluntary isometric contractions of the quadriceps.
  • Ability to comply with all study procedures and attend all experimental sessions.
  • Written informed consent obtained prior to participation.

Exclusion criteria

  • Previous knee surgery or traumatic knee injury within the past 12 months.
  • Complete or partial patellar tendon rupture.
  • Neurological disorders affecting lower limb strength or motor control.
  • Contraindications to electrical stimulation, including implanted electrical devices (e.g., pacemaker).
  • Current lower-limb radiculopathy or neuropathy.
  • Skin infections, open wounds, or dermatological conditions at the stimulation site.
  • Use of analgesics, anti-inflammatories, or corticosteroid injections within the past 48 hours.
  • Participation in another interventional study in the previous 30 days.
  • Pregnancy or suspected pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

19 participants in 3 patient groups

High-Frequency PPNS (100 Hz)
Experimental group
Description:
Participants receive peripheral percutaneous nerve stimulation (PPNS) applied to the femoral nerve at 100 Hz.
Treatment:
Device: Electrical stimulation
Low-Frequency PPNS (2 Hz)
Experimental group
Description:
Participants receive peripheral percutaneous nerve stimulation (PPNS) applied to the femoral nerve at 2 Hz.
Treatment:
Device: Electrical stimulation
Transcutaneous Electrical Nerve Stimulation (TENS)
Active Comparator group
Description:
Participants receive conventional transcutaneous electrical nerve stimulation (TENS) applied over the femoral nerve region using surface electrodes. Intensity is set at the maximal tolerated motor threshold to elicit visible quadriceps activation. The stimulation frequency and parameters are consistent with standard clinical practice for motor-level TENS.
Treatment:
Device: Electrical stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Javier Picañol Parraga Picañol, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems